As we continue to live in a world dominated by COVID-19, at CleanAir by Baker, we believe it’s more important than ever to support scientific discoveries across the globe.
A new and ground-breaking technology has come to the market when it comes to COVID-19 testing. Using Oxford Nanopore’s DNA/RNA sequencing technology, the LamPORE COVID-19 test is able to provide precise detection of the SARS-CoV-2 virus, that causes COVID-19. LamPORE is fully scalable and designed to enable high-volume screening and rapid, local testing, with its results obtained in under two hours.
Azithromycin is an antibiotic that is known to have anti-inflammatory effects and has previously proven to be effective in preventing severe bacterial respiratory tract infections in children with viral infections.
The anti-inflammatory effects within the drug might help to reduce an overactive immune response to COVID-19.
With the Inclusive Vaccine Alliance made up of France, Germany, Italy and The Netherlands, things have moved more slowly in Europe than in other countries when it comes to finding a vaccine. However, Astrazeneca recently concluded an agreement with the European Commission to supply up to 400 million doses of its AZD-1222 COVID-19 vaccine. They aim to deliver by the end of the year. In addition to Astrazeneca, the European Commission also intend to sign deals with Johnson & Johnson and Sanofi & GSK.
Vaccitech continues to innovate, refine and optimize their technology platforms in order to prevent infectious diseases. Preclinical data show that the new platform induces antibody and cell mediated immune responses when compared with the adenoviral platforms currently in vaccine trials.
The grant, given to Vaccitech by the UK Government is part of the UKRI-NIHR COVID-19 rapid response call.
Throughout The Netherlands in July, there were a total of 3,526 confirmed COVID-19 cases. Unfortunately, this has increased significantly to 15,602 confirmed cases throughout August, an uplift of 77.4%.
Here at CleanAir by Baker, we believe it is more important than ever to continue to #SupportScience and its discoveries worldwide.
Make sure you join us in #SupportingScience across all of our social media channels!
Follow us on Facebook, Twitter, Instagram and LinkedIn.
1. https://nanoporetech.com/about-us/news/oxford-nanopore-technologies-partners-uk-government-roll-out-lampore-new-generation, 2. https://www.medicalnewstoday.com/articles/can-antibiotics-treat-the-coronavirus-disease#can-they, 3. https://www.biopharma-reporter.com/Article/2020/08/18/AstraZeneca-J-J-and-Sanofi-GSK-set-to-sell-up-to-1.1bn-COVID-19-vaccines-to-EU, 4. https://www.genengnews.com/topics/bioprocessing/vaccitech-awarded-uk-grant-for-covid-vaccine-research/, 5. https://ourworldindata.org/coronavirus/country/netherlands?country=~NLD
Back to News
Because of Covid-19, our office staff of course also works at home. It might be that at some moments we are a bit less reachable by phone than you are used to from us. Please send us an e-mail: